We are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Reset all filters
01 20Alfred E Tiefenbacher GmbH
02 5Pharmathen SA
03 92care4
04 6Abiogen Pharma Spa
05 7Actavis Inc
06 5Adcock Ingram
07 3Alkem Laboratories
08 9Collegium Pharmaceutical
09 3Consilient Health
10 8Endo International
11 1G.L. Pharma GmbH
12 7G.L. Pharma Gmbh
13 6GL Pharma
14 80Grunenthal
15 2Health Biotech
16 2Hubei Gedian Humanwell Pharmaceutical
17 8Krka
18 3MEDOCHEMIE LTD
19 22Medical Valley
20 3Novagen Healthcare
21 9ORIFARM GROUP AS
22 9Orchid Pharma
23 7Precise Group
24 2RHODES PHARMACEUTICALS LP
25 3ROXANE
26 5Sandoz B2B
27 5Seqirus
28 1Vega Biotech Pvt. Ltd.
29 4West-ward Pharmaceutical Corp
30 12Blank
Reset all filters
01 7ER TABLET
02 4ER Tablet
03 10Extended Release Tablets
04 15Extended-Release Tablet
05 30Film Coated Tablet
06 8Oral Solution
07 5Prolonged Release Tablet
08 22Prolonged-Release Tablet
09 2SOLUTION;ORAL
10 12SR Tablet
11 3SRT
12 4Solution
13 2Syrup
14 2TAB
15 3TABLET
16 5TABLET (EXTENDED-RELEASE)
17 3TABLET (IMMEDIATE RELEASE)
18 14TABLET, EXTENDED RELEASE;ORAL
19 2TABLET; ORAL
20 12TABLET;ORAL
21 80Tablet
22 1Tapentadolo 100Mg 30 Joined' Oral Use Rp
23 1Tapentadolo 150Mg 30 Joined' Oral Use Rp
24 1Tapentadolo 200Mg 30 Joined' Oral Use Rp
25 1Tapentadolo 250Mg 30 Joined' Oral Use Rp
26 1Tapentadolo 25Mg 40 Combined Oral Use Rp
27 1Tapentadolo 50Mg 30 Joined' Oral Use Rp
28 10XR Tablet
29 5Blank
Reset all filters
01 29Approved
02 23Authorized
03 2Cancelled
04 1DISCN
05 34Deregistered
06 2EU Dossier Readiness-Q1 2020
07 4EU Dossier Readiness-Q3 2019
08 8Generic
09 9Generic EU CTD
10 28Marketed
11 8NARCOTICS (CDSA I)
12 5Originator
13 27Prescription
14 8RX
15 14Status- Early Development
16 12Under registration in India
17 52Blank
Reset all filters
01 3Ationdo
02 6Ationdo Depot
03 4NUCYNTA
04 5NUCYNTA ER
05 5NUCYNTA EXTENDED-RELEASE
06 3NUCYNTA IR
07 21Palexia
08 1Palexia 100 mg
09 1Palexia 50 mg
10 21Palexia Depot
11 6Palexia Retard
12 5Palexia SR
13 1Palexia SR 100 mg
14 1Palexia SR 200 mg
15 1Palexia SR 50 mg
16 14Palexia depot
17 5TADOMON
18 5TAPELOD
19 16TAPENTADOL
20 5TAPENTADOL HYDROCHLORIDE
21 3Tapemed Retard
22 1Tapencet ER
23 5Tapentadol Carefarm
24 3Tapentadol Consilient Health
25 6Tapentadol Depot Abiogen
26 6Tapentadol Depot G.L. Pharma
27 6Tapentadol Depot Medical Valley
28 1Tapentadol G.L. Pharma
29 1Tapentadol Gl Pharma
30 3Tapentadol Krka
31 10Tapentadol Medical Valley
32 1Tapentadol "Gl Pharma"
33 5Tapentadol "Krka"
34 6Tapentadol "Medical Valley"
35 10Yantil
36 6Yantil Depot
37 6Yantil Retard
38 58Blank
Reset all filters
01 5Australia
02 8Canada
03 24Denmark
04 3Estonia
05 20Germany
06 5Greece
07 34India
08 16Italy
09 28Norway
10 5South Africa
11 25Spain
12 63Sweden
13 30USA
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany